COVID-19: Melatonin as a potential adjuvant treatment
Top Cited Papers
- 1 June 2020
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 250, 117583
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Melatonin treatment improves adipose‐derived mesenchymal stem cell therapy for acute lung ischemia–reperfusion injuryJournal of Pineal Research, 2012
- Beneficial actions of melatonin in the management of viral infections: a new use for this “molecular handyman”?Reviews in Medical Virology, 2012
- Melatonin Protects CD4+ T Cells from Activation-Induced Cell Death by Blocking NFAT-Mediated CD95 Ligand UpregulationThe Journal of Immunology, 2010
- Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human PrimatesPLOS Pathogens, 2010
- Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trialCritical Care, 2008
- Prevention of LPS-Induced Acute Lung Injury in Mice by Mesenchymal Stem Cells Overexpressing Angiopoietin 1PLOS Medicine, 2007
- Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndromeRespirology, 2006
- The role of melatonin in immuno‐enhancement: potential application in cancerInternational Journal of Experimental Pathology, 2006
- Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to PathogenesisJournal of Virology, 2005
- Protective effects of melatonin in mice infected with encephalitis virusesArchives of Virology, 1995